Navigation Links
Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
Date:4/3/2009

ST. PAUL, Minn., April 3 /PRNewswire/ -- Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastroesophageal reflux disease (GERD) has commenced a pivotal clinical trial of its LINX(TM) Reflux Management System. The trial, which is being conducted at 15 leading academic and private medical centers in the U.S. and Europe, will evaluate the safety and effectiveness of the LINX System in patients suffering from GERD despite medical therapy.

GERD is caused by a defective lower esophageal sphincter, a ring-like muscular valve that surrounds the esophagus. When defective, it allows abnormal reflux of stomach acids and bile into the esophagus. Approximately 19 million adults in the U.S. suffer on a daily basis from the symptoms of GERD. Medical therapy, such as the daily use of proton pump inhibitors (PPIs), may improve heartburn symptoms but it does not address the mechanically defective sphincter, allowing gastric reflux to continue. Chronic gastric reflux may lead to numerous complications including ulcerations and esophageal cancer. The incidence of esophageal cancer is rising at a faster rate than any other cancer in the U.S.

Robert Ganz, M.D. of Minnesota Gastroenterology and a Principal Investigator in the trial shared these comments, "Many people who suffer from GERD do not get complete relief of symptoms with drug therapy. The LINX System is intriguing because it may provide both symptom relief and correction of the physiologic defect."

The LINX Reflux Management System is intended to restore the normal barrier function in the esophagus for patients who suffer from GERD and is designed to be an outpatient, minimally invasive procedure. The device is implanted laparoscopically, with the patient likely to resume normal activities and diet at discharge. In addition to its therapeutic benefits, Torax Medical anticipates that the LINX System will have
'/>"/>

SOURCE Torax Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
2. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
3. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
4. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
5. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
6. Premier Research Expands its Medical Device Operations to the United States
7. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
8. Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
9. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
10. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...all/--ERT(Nasdaq: ERES ),announcedtodaythatDr.Mich...Schneck,theCompany,sExecutiveVicePresidentandCFO,a...lthCareConferenceat1:30PMESTonDecember1,2009inNewY...hepresentationbyvisitingtheCompany,scorporatewebsi...edat http://www.corporate-ir.net/ireye/conflobby.z...
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Tattoo Removal on the Fastest U S Marine 62003 1Tattoo Removal on the Fastest U S Marine 62003 2FloatScope A New Device for Self Viewing Eye Floaters 62001 1FloatScope A New Device for Self Viewing Eye Floaters 62001 2Cell Therapeutics Inc 28CTI 29 to Present at 21st Annual Piper Jaffray Health Care Conference 14951 1
...to Reduced Premature Births, WATSONVILLE, Calif.,...study that shows folic acid supplements greatly,re...ral health officials,say not enough women are taki... to remember to take vitamins, but women (and,men)... visit their,supermarket,s produce aisle or farmer...
.... 5 Joseph F. Finn, Jr.,CPA, the Assignee for the...oday that The Committee for Orphan Drug Products o... Orphan Drug Designation for M40403 for the,preven...r patients,receiving radiotherapy., The developme...ead and,neck cancers is the major reason for poor ...
Other Medicine Technology:Folate in Strawberries May Contribute to Healthy Pregnancy 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 3
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
(Date:11/26/2009)...d Kim of the Live Life Again Center, a practice of...a growing number of physicians who are taking adv...ct with individuals who are interested in surgical.... Kim is utilizing Facebook to share before-and-af... the community. , Dallas,...
(Date:11/26/2009)...mp; Ennis, P.A. is offering free nationwide confid...irth control pills who have suffered a Deep Vein T... Attack or other related cardiac issues or had the...t 1-800-856-6405 or go to the firm’s website...ne case evaluation form. , ...
(Date:11/25/2009)...RNewswire-FirstCall/-- OnyxPharmaceuticals,Inc.(N...woinvestoreventsinDecember: ,, ASHBriefing ..., Principalinvestigatorswilldiscussdatapresentat...rymultiplemyeloma,asfeaturedatthe51stAmericanSocie...Orleans,LA.Theteleconferencewillbeginat9:00a.m.CT/...
(Date:11/25/2009)...Newswire/--Thanksgivingmealswillbedeliveredtoappro...areathankstoFaithInAction/VolunteerActionforAging,...nofSCANHealthPlan.Formorethan17yearstheseorganizat...hanksgivingmealstoseniorsinneedinLongBeach,Lakewoo...gcities. ,, "Ourwarmholidaymealsaredeliveredtop...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...amage due to blocked arteries remains the leading ...ut a Florida State University College of Medicine ...treating the problem. , Michael Blaber, a profess... vessels to restore blood flow in damaged areas of...
... Protections, OAKLAND, Calif., March 24 Some 10,...medical centers throughout the state ratified a,ne...rnia Nurses Association,announced today. The pact ...t, which Beth Kean, California Nurses Association/...
...ing is a,statement by AARP Legislative Policy Dire...oday declining AARP,s request to review a federal ...lth benefits for retirees when,they reach 65 and b...enged in lower federal courts., (Logo: http://ww...
...ational,Corporation (Nasdaq: PRXL ) announced tod...08 Smid Cap Conference. James Winschel, Senior Vic...king a formal presentation,on PAREXEL at 11:20 a.m...,s web site at, http://www.PAREXEL.com and a repl...
...ity dental research team has discovered evidence t...are more likely to develop gestational diabetes me... The study, led by Dr. Ananda P. Dasanayake, a pro...t six months of pregnancy. Twenty-two women develo...
... of Washington have uncovered how the bacterium St...(methicillin-resistant Staph aureus) superbug stra...nfection. The work, which was featured on the cove...ology, and his UW colleagues Dr. Anthony Richardso...
Other Medicine News:Health News:FSU researcher's 'mutant' proteins could lead to new treatment for heart disease 2Health News:UC RNs Overwhelmingly Approve New Contract 2Health News:UC RNs Overwhelmingly Approve New Contract 3Health News:AARP 'Deeply Disappointed' by Supreme Court Decision on Retiree Health Care Benefits 2Health News:PAREXEL International to Present at Bank of America 2008 Smid Cap Conference 2Health News:NYU dental researchers find evidence of periodontal disease leading to gestational diabetes 2Health News:Scientists uncover how superbug Staph aureus resists our natural defenses 2
...; Oxygen flowmeter with a Lexan®inner calibrat...bration and manufacturing defects. A wide range of...Also available with all popular inlet connections,... configurations. Our extra large knob coupled with...
...he entire series of time-tested Timeter® Class...ge of the needs of care providers and patients ali... in the craftsmanship. You can see it in the perfo...c Flowmeter is hand-crafted and engineered to the ...
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar & 2 Power Take Off
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/Y Bar & 1 Power Take Off
Medicine Products: